Seattle, WA (PRWEB) November 05, 2015
Quorum Review IRB, the industry leader in central IRB services, announces Dominic Chiarelli, JD, CIP, as a presenter at Public Responsibility in Medicine & Research’s 2015 Advancing Ethical Research Conference. The event takes place November 12-15, 2015 at the Hynes Convention Center in Boston, Massachusetts.
Mr. Chiarelli speaks on Special Topics for IRBs that Review FDA-Regulated Medical Device Investigations at 2:30PM on Friday, November 13. The presentation focuses on special topics and situations encountered by IRBs that review medical device studies and how best to address them to ensure subject safety, data quality, and regulatory compliance. Quorum Review’s Business Development Team will also be present in the exhibition hall at Booth #318 during the conference dates.
Mr. Chiarelli is a Senior Regulatory Attorney for Quorum Review, where he provides guidance and consultation on legal and regulatory matters to Quorum and its clients. Mr. Chiarelli received his Juris Doctor from the University of Washington in 2009 and was admitted to the Washington State Bar Association in 2010. He is also a Registered Patent Attorney and member of the Washington Patent Law Association. Before joining Quorum Review's Regulatory Department, Mr. Chiarelli worked as a regulatory analyst and IRB Member with Seattle Children's Research Institute where he was also a member of Children's Intellectual Property Group.
PRIM&R’s annual Advancing Ethical Research Conference is an educational event for professionals working in the field of human subject protection. The conference brings together over 2,500 industry professionals from hospitals, universities, government, and other research institutions in an educational, three-day networking opportunity.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report. Quorum’s best-in-class IRB services includes 15 Board meetings each week, 24-hour site review turnaround and 36-hour amendment review turnaround. The OnQ web portal hosts collaborative workspaces and Smart Forms. Review offerings at Quorum include full study review in the US and Canada, international ethics review, accelerated timelines for Phase 1 healthy studies, and faster less expensive alternatives for minimal risk studies.
Director, Client Relations & Marketing
Quorum Review IRB